0001354457-22-000413.txt : 20220719
0001354457-22-000413.hdr.sgml : 20220719
20220719114836
ACCESSION NUMBER: 0001354457-22-000413
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20220719
DATE AS OF CHANGE: 20220719
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: 4D Pharma PLC
CENTRAL INDEX KEY: 0001830162
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-250986
BUSINESS ADDRESS:
STREET 1: 9 BOND COURT
CITY: LEEDS
STATE: X0
ZIP: LS1 2JZ
BUSINESS PHONE: 44-0-113-895-0130
MAIL ADDRESS:
STREET 1: 9 BOND COURT
CITY: LEEDS
STATE: X0
ZIP: LS1 2JZ
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001830162
4D Pharma PLC
333-250986
5th Floor, 9 Bond Court
Leeds
X0
UNITED KINGDOM
LS1 2JZ
44-113-895-0130
American depositary shares and warrant
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2022-07-19
EX-99.25
2
lbpsdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC,
July 19, 2022, 4D pharma plc. The Nasdaq Stock Market LLC
(the Exchange) has determined to remove from listing
the American depositary shares and warrant of 4D pharma plc,
effective at the opening of the trading session on July 29, 2022.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified of the Staff determination on
June 27, 2022. The Company did not appeal the Staff
determination to the Hearings Panel. The Listing Council
did not call the matter for review. The Staff determination
to delist the Company common stock became final on
July 7, 2022.